Assistance Publique - Hôpitaux de Paris: Leukemia, Myeloid trials

The registry lists 14 Leukemia, Myeloid studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 6Phase 3 2No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid LeukemiaRecruitingNCT06225128
• Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction StudiesRecruitingNCT05772559
• Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line TreatmentRecruitingNCT05580861Phase 1/2
• Single-cell Dynamic Profiling in Adults With Newly Diagnosed Acute Myeloid Leukemia Treated With Intensive Chemotherapy. A THEMA Study"RecruitingNCT05304156
• Endothelial Activation Hemostasis Disturbances and Severe Bleeding Events in Hyperleukocytic Acute Myeloid LeukemiaStatus unknownNCT04133220
• MIF Involvement in AMLActive, not recruitingNCT03918655
• Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid MalignanciesStatus unknownNCT02333838Phase 2
• Observational Study of Patients Older Than 60 Years With Acute Myeloblastic LeukemiaStatus unknownNCT01966497
• Haploidentical NK-cell Infusion in Acute Myeloid LeukemiaCompletedNCT01947322Phase 1/2
• Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid LeukemiaCompletedNCT00797758Phase 2
• Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL PositiveCompletedNCT00763763Phase 2
• Timed-Sequential Induction in CBF-AMLCompletedNCT00428558Phase 3
• 5-azacytidine Valproic Acid and ATRA in AML and High Risk MDSCompletedNCT00339196Phase 2
• Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid LeukaemiaStatus unknownNCT00224614Phase 3